An Australian-led phase one trial tested a gene-editing therapy called CTX310 to lower cholesterol. The therapy uses CRISPR-Cas9 technology to target the liver and switch off a protein called ANGPTL3....
A new study from UCSF, the University of Adelaide, and the University of Toronto suggests that drinking coffee may help reduce atrial fibrillation (AF) recurrence. The study involved 200 adults with p...
A new research project in Australia is using AI and retinal imaging to detect systemic diseases early. Led by the Digital Health Cooperative Research Centre, Monash University, and Optain Health, the...
Australia has approved its first blood test for early Alzheimer’s diagnosis. Roche’s pTau 181 plasma test is now available outside research labs, mainly through the Florey Institute. It helps rule out...
A large study from Monash University shows that about half of midlife Australian women have poor sexual wellbeing. Women in early perimenopause are twice as likely to face desire and arousal issues co...
Health Innovation Hub Ireland has completed a pilot of Isaac Care, a digital health tool for older adults. The pilot involved 30 patients at University Hospital Galway and showed positive results. Par...
The South Australian government has allocated $3 million to expand lung cancer screening. This funding supports the national program launched in July, aiming to catch lung cancer early. It will increa...
The Australian government reduced public health spending by 30% in the past year, returning to pre-pandemic levels. Total spending was $5.4 billion in 2023-24, down $2.3 billion from the previous year...
The South Australian government has invested $3 million to support lung cancer screening and care. This adds to the national lung cancer screening program that started in July. The focus is on making...
Empagliflozin, sold as Jardiance, is now listed on the Australian PBS for more patients with kidney disease. The expansion will help over 65,000 Australians access the drug, which was first listed in...
The NSW Government has responded to the recent Drug Summit, supporting most of its 56 recommendations. The summit, held in December, involved over 700 participants and received nearly 3700 submissions...
New research shows weight-loss drugs like semaglutide and tirzepatide can lower urate levels in gout patients with hyperuricemia. The study used data from the Mass General Brigham health system in the...
A new study called the AQUATIC trial shows that taking aspirin with anticoagulants increases the risk of death and serious bleeding. The trial involved nearly 900 adults with chronic coronary syndrome...
The Menopause Society's 2025 conference shared new research on menopause and hormone therapy. Studies suggest early estrogen therapy may lower the risk of breast cancer, heart attack, and stroke. Wome...
Topcon Healthcare has acquired Toku, a New Zealand-founded AI health tech company. Toku’s platforms use retinal images to assess risks for heart disease, aging, and kidney issues. They have analysed o...
The AIHW report shows that in 2023–24, Australia increased hospital spending while primary care investment declined. Hospital costs rose by 1.2% to $113.8 billion, driven by more admissions. Meanwhile...
Australian health authorities are set to list faecal calprotectin testing on Medicare, making it easier for specialists and GPs to monitor inflammatory bowel disease. The new item will be available fo...
The RACGP is urging Northern Territory health officials to adopt the needle-free FluMist flu vaccine for children next year. Other Australian states like Western Australia, South Australia, New South...
The NSW government responded to the 2024 Drug Summit report. They supported some recommendations but rejected key proposals like stopping drug detection dogs at festivals. The government plans a new 1...
A new study analysed data from over 150 trials involving more than 58,000 people to compare the physical side-effects of 30 antidepressants. The research found significant differences in how these dru...
